The acquisition adds long-duration, recurring cash flows and diversifies the portfolio with commercial, royalty, and development-stage assets. Non-recourse financing and tax attributes enhance capital efficiency, while market exclusivity for YUPELRI® and milestone payments reduce risk and support long-term growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.